Montelukast Prescribing at CENTRAL PARK SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
354
Total Quantity
9,779
NHS Cost
£503
vs National Avg
-48.3%
CENTRAL PARK SURGERY prescribed 354 items of Montelukast over the last 12 months at a cost of £503 to the NHS. This is 48.3% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
35
Jul 2026
28
Jul 2026
30
Jul 2026
30
Jul 2026
20
Jul 2026
27
Jul 2026
26
Jul 2026
40
Jul 2026
32
Jul 2026
27
Jul 2026
31
Jul 2026
28
Prescribing Details
| Total Items | 354 |
|---|---|
| Total Quantity | 9,779 |
| Total NHS Cost | £503 |
| Presentations | 3 different forms |
| vs National Average | -48.3% |
Montelukast Prescribing Comparison
| This practice | 354 items |
|---|---|
| National average per practice | 685 items |
| Difference | -48.3% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.